New Research Identifies Airway Cells as a Critical Driver of Silicosis Progression

For decades, scientists believed that silicosis—a severe, irreversible lung disease caused by inhaling respirable crystalline silica dust—began primarily with immune cells responding to trapped silica particles in the lungs. New research from the Hudson Institute of Medical Research challenges that long-held belief and may fundamentally change how future treatments are developed. 

In a study published in Particle and Fibre Toxicology, researchers found that epithelial cells lining the airways and alveoli are major drivers of the inflammatory and fibrotic processes that lead to silicosis. The study, Epithelial NLRP3 Drives Silica-Induced Lung Injury and Fibrosis Through IL-18 and Pro-Fibrotic Neutrophil Recruitment, was authored by Maggie Lam, Kristian T. Barry, Christopher J. Hodges, Alison C. West, Christopher M. Harpur, Ashley Mansell, and Michelle D. Tate. 

The findings are particularly important as the world continues to confront a growing epidemic of silicosis among countertop fabrication workers exposed to crystalline silica artificial stone dust. 

A Growing Crisis Among Artificial Stone Workers 

Silicosis has historically been associated with mining, quarrying, and other industries involving silica exposure over many years. However, the emergence of crystalline silica artificial stone products has dramatically altered the disease landscape. 

Artificial stone, widely used for kitchen and bathroom countertops, contains exceptionally high levels of crystalline silica (at least 90%). During fabrication activities such as cutting, grinding, polishing, and finishing, workers are exposed to hazardous nano sized airborne silica particles. 

According to researchers, global silicosis prevalence increased by 91.4% between 1990 and 2019, while incidence rose by 64.6%. Unlike traditional silicosis, which often develops after decades of exposure, workers fabricating artificial stone slabs can develop severe lung disease within months or only a few years of exposure. 

Even after exposure ends, silica particles remain embedded in the lungs. Inflammation and scarring can continue to worsen long after a worker leaves the industry, making the need for effective treatments increasingly urgent. 

Solving a Longstanding Scientific Mystery 

Scientists have known for years that the NLRP3 inflammasome plays a major role in silica-induced lung injury. NLRP3 acts as an inflammatory alarm system inside cells, activating powerful inflammatory responses when damage occurs. 

Previous studies found that eliminating NLRP3 throughout the body reduced silicosis severity. However, researchers were puzzled when removing NLRP3 specifically from immune cells failed to provide protection. 

This contradiction led investigators to ask a critical question: If immune cells aren't driving NLRP3-related disease progression, what is? 

The answer appears to be the airway epithelium. 

Airway Epithelium and Silicosis

The research team demonstrated that epithelial cells lining both the alveoli and small airways serve as key early responders to silica exposure. When silica particles enter these cells, NLRP3 becomes activated, initiating a cascade of inflammatory events that ultimately contribute to fibrosis and lung destruction. 

As Dr. Maggie Lam, the study's first author, explained, the findings fundamentally change how researchers understand silicosis pathogenesis. 

Why Epithelial Cells Are So Important 

Unlike many immune cells, epithelial cells are located directly at the interface between inhaled air and lung tissue. They are often the first cells to encounter respirable silica particles. 

Researchers used sophisticated genetic models to selectively remove NLRP3 from: 

• Alveolar epithelial cells (Sftpc-positive cells) 

• Bronchiolar epithelial cells (Scgb1a1-positive cells) 

In both cases, removing NLRP3 significantly reduced inflammation, fibrosis, and lung injury. 

The findings showed that epithelial cells are far more than passive victims of silica exposure. Instead, they actively orchestrate much of the damaging inflammatory response that follows. 

IL-18 Emerges as a Key Driver of Silicosis 

One of the study's most important discoveries involves a signaling molecule known as interleukin-18 (IL-18). 

Researchers found that epithelial cells contain stored precursors of IL-18 that can be rapidly activated when NLRP3 detects silica-induced cellular stress. 

After silica exposure: 

• Epithelial NLRP3 triggered caspase-1 activation. 

• IL-18 production increased significantly. 

• Chronic inflammatory signaling was amplified. 

• Fibrosis progressed. 

When epithelial NLRP3 was removed, IL-18 levels dropped dramatically, reducing the inflammatory cascade that drives lung damage. 

Interestingly, these protective effects occurred without significant changes in transforming growth factor-beta (TGF-β), which is traditionally considered one of the body's primary fibrosis-promoting molecules. 

This suggests silicosis may develop through previously underappreciated pathways that are heavily dependent on epithelial IL-18 signaling. 

Researchers Identified a Pro-Fibrotic Neutrophil Population 

Another major finding involved a specialized group of immune cells known as Siglec-F-positive neutrophils. 

The study found that these neutrophils accumulated rapidly after silica exposure and appeared to possess highly pro-fibrotic characteristics. 

Compared to conventional neutrophils, Siglec-F-positive cells expressed elevated levels of genes associated with tissue remodeling and fibrosis, including: 

• Transforming growth factor-beta (TGF-β1) 

• Fibroblast growth factor-2 (FGF2) 

• Tumor necrosis factor (TNF) 

• Interleukin-1 beta (IL-1β) 

Researchers also observed increased expression of activation markers associated with tissue damage and remodeling. 

Notably, deleting epithelial NLRP3 significantly reduced recruitment of these pro-fibrotic neutrophils. 

By day 14 following silica exposure, approximately half of all neutrophils present in the lungs belonged to this pro-fibrotic subset. When NLRP3 was eliminated in epithelial cells, their numbers fell dramatically. 

The researchers also observed reduced levels of neutrophil elastase, an enzyme known to contribute to tissue destruction and fibrotic remodeling. 

Reduced Inflammation Led to Less Fibrosis 

The benefits of epithelial NLRP3 deletion extended beyond inflammation. 

Compared with control animals, mice lacking epithelial NLRP3 developed: 

• Less alveolitis (lung inflammation) 

• Lower collagen accumulation 

• Reduced fibrotic remodeling 

• Smaller silicotic nodules 

• Less α-SMA expression, a marker of activated scar-forming cells 

• Better preservation of normal lung architecture 

Perhaps most importantly, researchers found that epithelial NLRP3 appeared to regulate the growth and expansion of silicotic nodules rather than their initial formation. 

This distinction could have significant treatment implications. It suggests that future therapies might slow disease progression even after silica particles have already become permanently trapped in lung tissue. 

A New Direction for Future Treatments 

Currently, there is no cure for silicosis. 

Patients are typically offered supportive care that may include: 

• Symptom management 

• Oxygen therapy 

• Pulmonary rehabilitation 

• Lung transplantation in severe cases 

No approved therapy can stop or reverse the underlying disease process. 

The Hudson Institute researchers believe their findings point toward a promising new therapeutic strategy. 

Because epithelial cells line the airways directly, they may be accessible through inhaled medications. Future therapies aimed at blocking epithelial NLRP3 activation could potentially: 

• Interrupt disease at its earliest stages 

• Reduce IL-18-driven inflammation 

• Limit pro-fibrotic neutrophil recruitment 

• Slow fibrotic nodule expansion 

• Preserve lung tissue 

• Avoid many of the risks associated with systemic immune suppression 

The researchers describe this as a precision medicine approach—one that targets the disease where it begins rather than broadly suppressing the immune system. 

What This Means for Workers Exposed to Crystalline Silica Artificial Stone 

For workers already diagnosed with silicosis—or those concerned about past exposure—these findings provide important hope. 

Although prevention remains essential, especially in industries working with crystalline silica artificial stone, thousands of workers have already sustained significant exposures and remain at risk of progressive disease. 

This research identifies several new therapeutic targets and offers a better understanding of why silicosis continues to worsen even after exposure ends. 

By revealing the central role of epithelial NLRP3, IL-18 signaling, and pro-fibrotic neutrophils, the study opens the door to treatment approaches that may one day slow or prevent irreversible lung damage. 

Contact Brayton Purcell LLP 

If you worked with crystalline silica artificial stone and have been diagnosed with silicosis or another occupational lung disease, you may have legal rights. Brayton Purcell LLP has represented workers and families affected by toxic occupational exposures for decades. 

To learn more about your legal options, contact Brayton Purcell LLP for a free consultation. Our team can help evaluate your situation and answer questions about potential claims related to silica exposure and occupational lung disease. 

📞 Call (800) 361-2417 

🌐 Contact Us Online 

Source 

Lam M, Barry KT, Hodges CJ, West AC, Harpur CM, Mansell A, Tate MD. Epithelial NLRP3 drives silica-induced lung injury and fibrosis through IL-18 and pro-fibrotic neutrophil recruitment. Particle and Fibre Toxicology. 2026. DOI: 10.1186/s12989-026-00682-9. 

Additional reporting based on the Hudson Institute of Medical Research article by Rob Clancy.